| name | endo-annual-hormonal-testing-post-rt-hypopituitarism |
| description | Recommends annual hormonal testing of patients following radiotherapy to monitor for hypopituitarism and other delayed radiation effects. Use in survivorship care after RT when patients have received pituitary or hypothalamic RT/SRT. |
Annual hormonal testing after radiotherapy for hypopituitarism and delayed effects
STEP 1 — Gather Information
Collect details of radiotherapy (modality, dose, fractionation, date), prior pituitary surgery, baseline pituitary hormone levels, and any symptoms suggestive of hypopituitarism (fatigue, cold intolerance, loss of libido, menstrual changes, etc.).
STEP 2 — Rule In / Rule Out
Determine if the patient received pituitary/hypothalamic radiotherapy (RT or SRT). If yes, proceed to Step 3; if no, this skill does not apply and further testing per this guideline is not indicated.
STEP 3 — Classify or Stratify
Stratify by time since radiotherapy: if <6 months post-RT, defer testing until at least 6 months to allow transient hormone changes to resolve; if ≥6 months, proceed to annual testing.
STEP 4 — Decide
Order a comprehensive pituitary hormone panel (IGF-1, TSH/free T4, morning cortisol or ACTH stimulation test, LH/FSH with estradiol/testosterone, prolactin) and schedule repeat testing every 12 months.
Clinical Guardrails / Mimics / Pitfalls
Hypopituitarism may be asymptomatic; do not rely on symptoms alone. Avoid testing only IGF-1; assess all pituitary axes. Do not test earlier than 6 months post-RT due to transient fluctuations. Radiation‑induced optic neuropathy or cognitive changes are separate delayed effects not captured by hormonal testing.
Concrete Clinical Example
A 48‑year‑old man with a non‑functioning pituitary macroadenoma underwent gross‑total resection followed by adjuvant SRT (30 Gy in 5 fractions). At 14 months post‑RT he reports fatigue and mild cold intolerance. Hormonal panel reveals low IGF‑1, low TSH with low free T4, and subnormal cortisol, leading to diagnosis of central hypothyroidism and secondary adrenal insufficiency; he is started on levothyroxine and hydrocortisone replacement with annual follow‑up.
Source: Acromegaly: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2014, DOI:10.1210/jc.2014-2700
